NYSE:ZBH - Zimmer Biomet Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $105.78 -1.47 (-1.37 %) (As of 12/19/2018 04:59 AM ET)Previous Close$107.25Today's Range$104.69 - $108.2552-Week Range$104.28 - $134.55Volume2.04 million shsAverage Volume1.18 million shsMarket Capitalization$22.23 billionP/E Ratio13.17Dividend Yield0.88%Beta1.16 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Zimmer Biomet (NYSE:ZBH) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.24 Wall Street analysts have issued ratings and price targets for Zimmer Biomet in the last 12 months. Their average twelve-month price target is $133.3333, suggesting that the stock has a possible upside of 26.05%. The high price target for ZBH is $168.00 and the low price target for ZBH is $96.00. There are currently 3 sell ratings, 8 hold ratings and 13 buy ratings for the stock, resulting in a consensus rating of "Hold."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: HoldHoldBuyBuyConsensus Rating Score: 2.422.452.582.76Ratings Breakdown: 3 Sell Rating(s)8 Hold Rating(s)13 Buy Rating(s)0 Strong Buy Rating(s)2 Sell Rating(s)8 Hold Rating(s)12 Buy Rating(s)0 Strong Buy Rating(s)1 Sell Rating(s)8 Hold Rating(s)15 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)7 Hold Rating(s)17 Buy Rating(s)1 Strong Buy Rating(s)Consensus Price Target: $133.3333$134.6316$135.10$137.7143Price Target Upside: 26.05% upside17.81% upside7.82% upside23.50% upsideZimmer Biomet (NYSE:ZBH) Consensus Price Target History Zimmer Biomet (NYSE:ZBH) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails12/17/2018Credit Suisse GroupInitiated CoverageUnderperform$102.00Medium12/6/2018OppenheimerSet Price TargetBuy$135.00Low11/27/2018UBS GroupInitiated CoverageBuy ➝ Buy$140.00High10/29/2018Leerink SwannLower Price TargetOutperform$146.00 ➝ $141.00Low10/29/2018Jefferies Financial GroupLower Price TargetBuy ➝ Buy$145.00 ➝ $140.00Low10/29/2018CitigroupLower Price TargetNeutral ➝ Neutral$129.00 ➝ $122.00Medium10/29/2018BarclaysLower Price TargetUnderweight ➝ Sell$131.00 ➝ $119.00Medium10/28/2018BTIG ResearchReiterated RatingHoldLow10/11/2018Morgan StanleyBoost Price TargetOverweight$140.00 ➝ $149.00High8/27/2018Needham & Company LLCReiterated RatingBuy$150.00High8/27/2018Cantor FitzgeraldReiterated RatingBuy$150.00High7/30/2018Piper Jaffray CompaniesBoost Price TargetNeutral$110.00 ➝ $120.00Low7/30/2018Robert W. BairdBoost Price TargetNeutral ➝ Neutral$121.00 ➝ $132.00Low7/30/2018Raymond JamesBoost Price TargetOutperform ➝ Outperform$135.00 ➝ $145.00Low7/30/2018JMP SecuritiesBoost Price TargetMarket Outperform ➝ Outperform$133.00 ➝ $140.00Medium7/30/2018Canaccord GenuityBoost Price TargetHold ➝ Hold$122.00 ➝ $125.00Medium6/27/2018Sanford C. BernsteinInitiated CoverageUnderperform$96.00High6/22/2018ArgusDowngradeBuy ➝ HoldHigh4/2/2018Evercore ISIInitiated CoverageIn-Line$115.00Low1/31/2018Stifel NicolausUpgradeHold ➝ Buy$120.00 ➝ $168.00Low1/30/2018BMO Capital MarketsReiterated RatingBuy$144.00Low1/29/2018SunTrust BanksBoost Price TargetBuy$142.00Medium12/19/2017Goldman Sachs GroupUpgradeSell ➝ Neutral$125.00Low12/19/2017Wells Fargo & CoUpgradeMarket Perform ➝ OutperformLow11/14/2017Deutsche BankUpgradeHold ➝ Buy$128.00N/A11/9/2017Edward JonesUpgradeHold ➝ BuyN/A11/7/2017Royal Bank of CanadaLower Price TargetOutperform$125.00N/A8/24/2017GabelliInitiated CoverageBuy$142.00Low7/14/2017Bank of AmericaReiterated RatingBuy ➝ Buy$158.00Medium7/12/2017GuggenheimUpgradeNeutral ➝ Buy$157.00Medium1/5/2017JPMorgan Chase & Co.Set Price TargetBuy$134.00N/A(Data available from 12/19/2016 forward) This page was last updated on 12/19/2018 by MarketBeat.com StaffFeatured Article: What are the benefits of a balanced fund?